New research reveals that patients who stop using blockbuster slimming jabs like Wegovy and Mounjaro can put back on shed pounds far faster than those who stop conventional diet and exercise plans.
Published data in a major health publication shows that while obese individuals can lose substantial amounts of their total mass while on the medication, the weight comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals purchasing such medications should be informed of the risk of rapid weight regain when the therapy ends," warns lead investigator Dr. Susan Jebb.
Such speed of recovery means a return to original mass in about 18 months.
Analyzing Approaches
The study, which looked at dozens of trials involving over 9,000 of participants, compared the results of the injectable medications with conventional dieting.
Researchers point out that individuals who lose weight through diet and exercise usually have a slower creep back—around 100 grams monthly—after stopping.
Understanding the Fast Rebound
Doctors suggest the mode of action of the injections accounts for the amplified rebound.
The injections imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Sustained high doses of the hormone concentrations far above than the body's typical production may cause the system to generate a reduced amount of its own natural hormone, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Stopping of this GLP-1 'fix' leads to appetite is unsuppressed, making binge eating much more probable."
An Ongoing Disease?
Health authorities recommend the injections for people with obesity-related health risks, alongside recommended diet and exercise modifications.
A number of clinicians argue that, due to the significant potential of weight regain, the treatment is often long-term.
This opinion is reinforced by drug manufacturers, who say that the findings "emphasize the persistent character of obesity," comparing it to managing diseases like hypertension.
User Experiences
Individuals who have come off the medication explain a intense resurgence of cravings.
"It was like a switch flipping and I was suddenly ravenous," said a patient.
The struggle is compounded if patients have not developed sustainable dietary or behavioural modifications during therapy.
Significant Interest
Survey data suggest that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with interest remaining high.
- Adoption is higher among females than males.
- The middle-aged age group shows the greatest level of interest.
- A large proportion access the drugs through private healthcare rather than public health services.
Ultimately, clinicians caution that while the jabs are powerful agents for shedding pounds, they are not a permanent cure and lasting health benefits likely depends on combined lifestyle management.